Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06798961 · ClinicalTrials.gov registry record
Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)
A clinical trial of Cardiac Death and Cardiac Death, Sudden, sponsored by United States Naval Medical Center, San Diego.
- Active
- Registry status
- 1,000
- Enrollment target
- 1
- Study location
NCT06798961: Active study of Cardiac Death and Cardiac Death, Sudden, sponsored by United States Naval Medical Center, San Diego.
NCT06798961 is a study of Cardiac Death and Cardiac Death, Sudden that is active but no longer recruiting, run by United States Naval Medical Center, San Diego. The registered enrollment target is 1,000 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06798961, a study of Cardiac Death and Cardiac Death, Sudden, is active but no longer recruiting, sponsored by United States Naval Medical Center, San Diego.
- ACTIVE NOT RECRUITING
- Registry status
- 1,000 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators propose a secondary chart review using EMR data to identify risk factors for sudden cardiac death in active-duty members diagnosed with an accessory pathway between the ages of 18-40.
Primary Outcome
The goal of LEAD AP is to investigate the long-term outcomes of patients diagnosed with an accessory pathway during their military service; with the goal of identifying additional risk factors associated with sudden cardiac death to help with risk stratification and guide ablation for patients diagnosed with accessory pathways between the ages of 18-40.
Conditions Studied
Interventions
- PROCEDURE Ablation
- PROCEDURE Standard of care without ablation
Study Locations (1)
California
- Naval Medical Center San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2025-12 |
What the registry record for NCT06798961 still lists
NCT06798961 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 3 conditions, with Cardiac Death appearing as the primary indexed condition, and to 2 interventions - of which Ablation is the first listed.
NCT06798961 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06798961 about?
NCT06798961 is a clinical study titled "Longitudinal Evaluation of Active-Duty Personnel with Accessory Pathways (LEAD-AP)". The investigators propose a secondary chart review using EMR data to identify risk factors for sudden cardiac death in active-duty members diagnosed with an accessory pathway between the ages of 18-40.
What is the current status of trial NCT06798961?
This trial is currently active not recruiting. The enrollment target is 1,000 participants. The study started on 2024-11-01. Estimated completion is 2025-12.
What conditions does trial NCT06798961 study?
This clinical trial studies the following conditions: Cardiac Death, Cardiac Death, Sudden, Wolf Parkinson White Syndrome.
What interventions are being tested in trial NCT06798961?
The interventions under investigation include: Ablation (PROCEDURE), Standard of care without ablation (PROCEDURE).
Who is sponsoring clinical trial NCT06798961?
This trial is sponsored by United States Naval Medical Center, San Diego, which has 41 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06798961 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI